BioCentury
ARTICLE | Company News

Maxim sells vaccine business

May 26, 2000 7:00 AM UTC

MAXM completed an agreement to sell its MaxVax mucosal vaccine technology, and settle an arbitration related to the technology, for $3 million. The company will record a $2.1 million gain this quarter...